Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares Repurchased
Ratios

Indivior Pharmaceuticals (INDV) R&D In Process (2024)

Indivior Pharmaceuticals has reported R&D In Process over the past 1 years, most recently at $1.0 million for Q3 2024.

  • Quarterly results put R&D In Process at $1.0 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.0 million (changed N/A YoY), and the annual figure for FY2024 was $1.0 million, down 99.38%.
  • R&D In Process for Q3 2024 was $1.0 million at Indivior Pharmaceuticals.
  • Over the last five years, R&D In Process for INDV hit a ceiling of $1.0 million in Q3 2024 and a floor of $1.0 million in Q3 2024.